Pharmacokinetic evaluation of bazedoxifene for the treatment of osteoporosis

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.9, Iss.7, 2013-07, pp. : 883-892

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bazedoxifene: A Review of its Use in the Treatment of Postmenopausal Osteoporosis

By Duggan Sean T. McKeage Kate

Drugs, Vol. 71, Iss. 16, 2011-11 ,pp. : 2193-2212

Adis International

Access to resources Recommend Favorite

Bazedoxifene a boost for bones in postmenopausal osteoporosis

Inpharma, Vol. 1, Iss. 1611, 2007-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Bazedoxifene + conjugated estrogens in HT for the prevention of osteoporosis and treatment of vasomotor symptoms associated with the menopause

By Tella Sri Harsha Gallagher John Christopher

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 17, 2013-12 ,pp. : 2407-2420

Informa Healthcare

Access to resources Recommend Favorite

Bazedoxifene and bazedoxifene combined with conjugated estrogens for the management of postmenopausal osteoporosis

By Lewiecki E Michael

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 10, 2007-10 ,pp. : 1663-1672

Informa Healthcare

Access to resources Recommend Favorite

Bazedoxifene: A Guide to Its Use in Postmenopausal Osteoporosis

By Keating Gillian M. Lyseng-Williamson Katherine A. Duggan Sean T. McKeage Kate

Drugs & Aging, Vol. 29, Iss. 4, 2012-04 ,pp. : 329-334

Adis International

Access to resources Recommend Favorite